In December 2023, the U.S. Department of Health and Human Services, in collaboration with the Food and Drug Administration (FDA), […]

In the ever-evolving field of healthcare, bringing a new medicine to market is a complex and highly regulated process. For

The life sciences landscape is a bustling hub, constantly buzzing with innovation and adaptation. But staying ahead of the curve

In the dynamic world of pharmaceuticals, staying ahead of regulatory changes is crucial for life sciences professionals, particularly those involved

Attention generic drug manufacturers! The FDA’s recent revision to its “ANDA Submissions—Amendments and Final Approval Requests” guidance throws open a

Imagine Affordable access to life-saving biosimilars and generics, a medical landscape where cost doesn’t limit access to crucial therapies. But

The development of new drugs involves a rigorous journey, with regulations guiding each step. One crucial aspect is charging for

For decades, the life sciences industry has relied on mountains of paper to navigate the complex world of regulatory submissions.

The world of regulatory affairs, once a realm of meticulous document reviews and labyrinthine compliance procedures, is on the cusp

For decades, life sciences companies have navigated a labyrinth of regulations, with each country seemingly operating under its own unique